The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal analysis and regulatory compliance.
Following the collapse of a development deal between TWG and the city, we’re not sure it makes sense to seek another round of ideas from developers without deeper research into what’s possible.
If you want to understand where America’s biotech future is being built, stop looking east and west. Look at what’s happening right now in central Indiana.
The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, according to speakers at IBJ’s Life Sciences Power Breakfast.
The focus of the agreement is to meet the evolving needs of Indiana’s orthopedic sector, which represents one-third of the industry’s global workforce.
We all know that moment when someone is right in front of us, clearly needing support, and we feel a tug. To act. To intervene. To help. But what happens when what feels like empathy or care pulls us into taking on what is not ours to carry? Sometimes, our care unintentionally undermines the very […]
The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.
As the new president and CEO of Indianapolis-based TechPoint, Eric Christopher’s focus is on helping tech companies — and the state’s tech industry itself — grow and achieve big things.
The Indianapolis-based pharmaceutical giant and the state’s Office of Energy Development signed a nonbinding letter of intent to explore the potential deployment of small modular reactors.
